DXCM vs KEYS · P/E 63, rev $4.03B vs P/E 57, rev $4.98B
DexCom Inc (DXCM) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the DXCM and KEYS stock pages for the full models.
Not investment advice.